Philip Morris cited growth in Iqos, its inhalable smoke-free product, as well as Zyn nicotine pouches, which won FDA authorization in 2024.

While the long-term effects of Zyn remain unclear, it cannot be assumed that they are safe. History has shown that nicotine ...